OrbusNeich

Industry · 14 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Active Not Recruiting	Support C Post-Market Registry Coronary Arteriosclerosis	—	2025-07-09
Recruiting	VITUS Post-Market Registry Peripheral Arterial Disease, Peripheral Arterial Occlusive Disease	—	2025-05-22
Active Not Recruiting	EucaLimus Post-Market Registry Coronary Arterioscleroses	—	2025-03-14
Completed	Sapphire 3 CTO Study Coronary Artery Disease, Coronary Disease, Myocardial Ischemia	N/A	2024-11-06
Completed	Scoreflex TRIO - Scoring PTCA Catheter Coronary Arteriosclerosis	N/A	2023-04-27
Completed	Scoreflex NC - Scoring PTCA Catheter Coronary Artery Disease, Coronary Disease, Myocardial Ischemia	N/A	2019-02-27
Completed	Sapphire II PRO US Clinical Study Coronary Artery Disease, Coronary Disease, Myocardial Ischemia	N/A	2017-05-05
Completed	Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus Coronary Arteriosclerosis	N/A	2015-05-01
Completed	MASCOT - Post Marketing Registry Coronary Artery Disease, Atherosclerosis	—	2014-06-01
Completed	HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt Coronary Arteriosclerosis, Non ST Segment Elevation Acute Coronary Syndrome	N/A	2014-02-01
Terminated	Deutsches Dual Therapy Stent Register Coronary Artery Disease	—	2013-07-01
Completed	Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of Coronary Artery Disease, Atherosclerosis, Acute Coronary Syndrome (ACS)	Phase 2	2011-10-01
Completed	Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent Coronary Artery Lesions	Phase 2	2009-11-01
Completed	Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth Coronary Artery Disease, Coronary Artery Stenosis	Phase 4	2006-08-01